Cargando…

1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?

BACKGROUND: OPAT is widely implemented in the United States. However, there are concerns surrounding discharge of IDU with a peripherally inserted central catheter (PICC). The objective of this study was to evaluate the characteristics and treatment outcomes of IDUs discharged on OPAT. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizvi, Hira, Baratz, Nathalie, Hadid, Hind, Bardossy, Ana C, Herc, Erica, Misikir, Helina, Chen, Anne, Markowitz, Norman, Zervos, Marcus J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255560/
http://dx.doi.org/10.1093/ofid/ofy210.864
_version_ 1783373970067685376
author Rizvi, Hira
Baratz, Nathalie
Hadid, Hind
Bardossy, Ana C
Herc, Erica
Misikir, Helina
Chen, Anne
Markowitz, Norman
Zervos, Marcus J
author_facet Rizvi, Hira
Baratz, Nathalie
Hadid, Hind
Bardossy, Ana C
Herc, Erica
Misikir, Helina
Chen, Anne
Markowitz, Norman
Zervos, Marcus J
author_sort Rizvi, Hira
collection PubMed
description BACKGROUND: OPAT is widely implemented in the United States. However, there are concerns surrounding discharge of IDU with a peripherally inserted central catheter (PICC). The objective of this study was to evaluate the characteristics and treatment outcomes of IDUs discharged on OPAT. METHODS: This is a retrospective observational study conducted on patients discharged from an Infectious Diseases unit at a quaternary academic healthcare center in Detroit. Charts of all IDUs discharged on OPAT between 2011 and 2017 were reviewed. Current or former IDU were discharged on OPAT if they met the following criteria: self-reported history of IDU, stable living conditions, controlled psychiatric illness (if present), and willingness to sign a discharge agreement to refrain from using the PICC as a route for illicit drugs. Patients were categorized based on clinic follow-up vs. no clinic follow-up. Outcomes evaluated were: cured (completed treatment and symptom free for 1 month after completion), improved (symptoms were improved but there was no confirmation of treatment completion); and relapsed (readmitted within 30 days for the same infection or sequela). Outcomes of patients with no clinic follow-up were based on chart review of subsequent emergency department visits or admissions. RESULTS: Patient characteristics are shown in Table 1. Of the 61 patients evaluated, 33 (54.1%) attended clinic follow-up and 28 (45.9%) did not. Outcomes based on clinic follow-up are shown in Table 2. Of the 18 patients who were cured, 16 attended clinic follow-up vs. two who did not. CONCLUSION: This study demonstrates that some IDUs can be discharged safely on OPAT. Patients with clinic follow-up had improved outcomes compared with those who did not. Further studies are needed to look at other predictors of outcome in this patient population. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255560
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62555602018-11-28 1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe? Rizvi, Hira Baratz, Nathalie Hadid, Hind Bardossy, Ana C Herc, Erica Misikir, Helina Chen, Anne Markowitz, Norman Zervos, Marcus J Open Forum Infect Dis Abstracts BACKGROUND: OPAT is widely implemented in the United States. However, there are concerns surrounding discharge of IDU with a peripherally inserted central catheter (PICC). The objective of this study was to evaluate the characteristics and treatment outcomes of IDUs discharged on OPAT. METHODS: This is a retrospective observational study conducted on patients discharged from an Infectious Diseases unit at a quaternary academic healthcare center in Detroit. Charts of all IDUs discharged on OPAT between 2011 and 2017 were reviewed. Current or former IDU were discharged on OPAT if they met the following criteria: self-reported history of IDU, stable living conditions, controlled psychiatric illness (if present), and willingness to sign a discharge agreement to refrain from using the PICC as a route for illicit drugs. Patients were categorized based on clinic follow-up vs. no clinic follow-up. Outcomes evaluated were: cured (completed treatment and symptom free for 1 month after completion), improved (symptoms were improved but there was no confirmation of treatment completion); and relapsed (readmitted within 30 days for the same infection or sequela). Outcomes of patients with no clinic follow-up were based on chart review of subsequent emergency department visits or admissions. RESULTS: Patient characteristics are shown in Table 1. Of the 61 patients evaluated, 33 (54.1%) attended clinic follow-up and 28 (45.9%) did not. Outcomes based on clinic follow-up are shown in Table 2. Of the 18 patients who were cured, 16 attended clinic follow-up vs. two who did not. CONCLUSION: This study demonstrates that some IDUs can be discharged safely on OPAT. Patients with clinic follow-up had improved outcomes compared with those who did not. Further studies are needed to look at other predictors of outcome in this patient population. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255560/ http://dx.doi.org/10.1093/ofid/ofy210.864 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Rizvi, Hira
Baratz, Nathalie
Hadid, Hind
Bardossy, Ana C
Herc, Erica
Misikir, Helina
Chen, Anne
Markowitz, Norman
Zervos, Marcus J
1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
title 1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
title_full 1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
title_fullStr 1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
title_full_unstemmed 1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
title_short 1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
title_sort 1027. outpatient parenteral antimicrobial therapy (opat) in injection drug users (idus): is it safe?
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255560/
http://dx.doi.org/10.1093/ofid/ofy210.864
work_keys_str_mv AT rizvihira 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT baratznathalie 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT hadidhind 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT bardossyanac 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT hercerica 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT misikirhelina 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT chenanne 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT markowitznorman 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe
AT zervosmarcusj 1027outpatientparenteralantimicrobialtherapyopatininjectiondrugusersidusisitsafe